COYA Covered Call Strategy
COYA (Coya Therapeutics, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.
Coya Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapeutic agents that fine-tune the function of regulatory T cells (Tregs). Its therapeutic pipeline leverages diverse approaches, including biologics designed to enhance Treg activity, Treg-derived exosomes, and personalized autologous Treg cell therapies. Among its lead candidates is COYA 101, an autologous regulatory T-cell product that has successfully completed Phase 2a clinical trials for treating Amyotrophic Lateral Sclerosis (ALS). Moving towards Investigational New Drug (IND) applications are two key candidates: COYA 301 and COYA 302. COYA 301 is a Treg-enhancing biologic aimed at treating Frontotemporal Dementia. Meanwhile, COYA 302 is a dual-action biologic combination, suitable for subcutaneous or intravenous delivery, engineered to not only boost Treg function but also to diminish harmful T effector cell activity and activated macrophages in neurodegenerative and autoimmune disorders.
COYA (Coya Therapeutics, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $100.1M, a beta of 0.62 versus the broader market, a 52-week range of 3.71-7.75, average daily share volume of 167K, a public-listing history dating back to 2022, approximately 8 full-time employees. These structural characteristics shape how COYA stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.
A beta of 0.62 indicates COYA has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.
What is a covered call on COYA?
A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income.
Current COYA snapshot
As of June 30, 2026, spot at $5.95, ATM IV 242.30%, IV rank 49.76%, expected move 69.47%. The covered call on COYA below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 17-day expiry.
Why this covered call structure on COYA specifically: COYA IV at 242.30% is mid-range versus its 1-year history, so the credit collected on a COYA covered call sits in line with its long-run distribution, with a market-implied 1-standard-deviation move of approximately 69.47% (roughly $4.13 on the underlying). The 17-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated COYA expiries trade a higher absolute premium for lower per-day decay. Position sizing on COYA should anchor to the underlying notional of $5.95 per share and to the trader's directional view on COYA stock.
COYA covered call setup
The COYA covered call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With COYA near $5.95, the first option leg uses a $6.25 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed COYA chain at a 17-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 COYA shares for the stock leg in covered calls and collars).
| Action | Type | Strike / Basis | Premium (est) |
|---|---|---|---|
| Buy 100 shares | Stock | $5.95 | long |
| Sell 1 | Call | $6.25 | N/A |
COYA covered call risk and reward
- Net Premium / Debit
- N/A
- Max Profit (per contract)
- Unbounded
- Max Loss (per contract)
- Unbounded
- Breakeven(s)
- None on modeled curve
- Risk / Reward Ratio
- N/A
Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium.
COYA covered call payoff curve
Modeled P&L at expiration across a range of underlying prices for the covered call on COYA. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.
When traders use covered call on COYA
Covered calls on COYA are an income strategy run on existing COYA stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
COYA thesis for this covered call
The market-implied 1-standard-deviation range for COYA extends from approximately $1.82 on the downside to $10.08 on the upside. A COYA covered call collects premium on an existing long COYA position, trading off upside above the short call strike for immediate income; the short strike selection should reflect the trader's view on whether COYA will breach that level within the expiration window. Current COYA IV rank near 49.76% is mid-range against its 1-year distribution, so the IV signal is neutral; the covered call thesis on COYA should anchor more to the directional view and the expected-move geometry. As a Healthcare name, COYA options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to COYA-specific events.
COYA covered call positions are structurally neutral to slightly bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. COYA positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move COYA alongside the broader basket even when COYA-specific fundamentals are unchanged. Short-premium structures like a covered call on COYA carry tail risk when realized volatility exceeds the implied move; review historical COYA earnings reactions and macro stress periods before sizing. Always rebuild the position from current COYA chain quotes before placing a trade.
Frequently asked questions
- What is a covered call on COYA?
- A covered call on COYA is the covered call strategy applied to COYA (stock). The strategy is structurally neutral to slightly bullish: A covered call pairs long stock with a short out-of-the-money call, collecting premium and capping upside above the short strike in exchange for income. With COYA stock trading near $5.95, the strikes shown on this page are snapped to the nearest listed COYA chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
- How are COYA covered call max profit and max loss calculated?
- Max profit equals short-strike minus cost basis plus premium times 100; max loss is cost basis minus premium (at zero). Breakeven is cost basis minus premium. For the COYA covered call priced from the end-of-day chain at a 30-day expiry (ATM IV 242.30%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
- What is the breakeven for a COYA covered call?
- The breakeven for the COYA covered call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current COYA market-implied 1-standard-deviation expected move is approximately 69.47%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
- When should you consider a covered call on COYA?
- Covered calls on COYA are an income strategy run on existing COYA stock positions; traders typically sell calls at 25-35 delta with 30-45 days to expiration to balance premium against upside cap.
- How does current COYA implied volatility affect this covered call?
- COYA ATM IV is at 242.30% with IV rank near 49.76%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.